Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine, granisetron, or nitroglycerin added to ropivacaine for intravenous regional anesthesia in forearm surgery
IRCT20141209020258N123Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine, granisetron, nitroglycerin and ropivacaine in postoperative pain (4 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Sensory block duration, Motor block duration and 2 more. Started Jul 2019; status: completed.
02
Drugs
dexmedetomidinegranisetronnitroglycerinropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20141209020258N123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N123.